Skip to main content

Table 2 Change in HbA1c, blood pressure, diabetic medication use, and BMI

From: The impact of the COVID-19 pandemic shelter in place on glycemic control, blood pressure control, and body mass index among diabetic patients at Kaiser Permanente Northern California: a retrospective cohort study

Period

HbA1c (%)

BMI (kg/m2)

SBP (mmHg)

DBP (mmHg)

OHA Users

Insulin Users

Pre-SiP

7.45 (1.48)

31.81 (7.29)

133.04 (13.84)

70.79 (9.97)

72.06

28.64

Post-SiP

7.49 (1.57)

31.51 (7.39)

134.12 (15.68)

71.30 (10.52)

72.41

29.25

  1. Glycated hemoglobin (HbA1c), body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP), oral hypoglycemic agent (OHA) are compared between pre-SiP and post-SiP time periods. Values reported as mean (standard deviation) for continuous variables (HbA1c, BMI, SBP, DBP) and as a proportion (%) for OHA/Insulin users. Note p < 0.0001 for all pre- and post-SiP comparisons